Qiyuan Pharmaceutical through the customs AEO advanced enterprise certification

Qiyuan Sinopremedy has become the technology innovation center of Chinese patent medicine in Ningxia

Qiyuan Pharmaceutical in 2022 three systems of supervision and certification successfully completed

Production without school staff charge busy

QI Yuan Sinophosphance has passed the acceptance of key R&D projects in the district